Results
Orchid Pharma Q2 FY27 Net Profit Surges to INR28.6 Crores
Orchid Pharma reported Q2 FY27 revenue growth of 14% YoY to INR341 crores, with EBITDA surging 148% to INR52 crores.
Gross margin improved 8 percentage points to 39% due to normalized inventory, bette